Severe Aplastic Anaemia Working Party (SAAWP)
COVID-19
Type d'étude:
Numéro de l'étude:
84090085
Type de traitement:
Maladies:
Bone marrow failure
Titre court:
SARS-CoV-2 vaccination in non-transplanted AA/PNH patients
Objectif principal:
To study the impact of SARS-CoV-2 vaccination for non-transplanted AA and/or PNH patients
Principaux critères d'inclusion:
Patients are eligible if:
- they have been diagnosed with AA and/or PNH, irrespective of vaccination status;
- they have received the first SARS-CoV-2 vaccination before 01-08-2021;
- they are under active follow-up (to allow CRF completion);
- they have not yet undergone a bone marrow transplant.
Patients are not eligible if:
- they have undergone bone marrow transplant;
- they are paediatric patients (due to vaccinations not being undertaken in this population at the start of this study, this may be revisited at a later date)
- they have been diagnosed with AA and/or PNH, irrespective of vaccination status;
- they have received the first SARS-CoV-2 vaccination before 01-08-2021;
- they are under active follow-up (to allow CRF completion);
- they have not yet undergone a bone marrow transplant.
Patients are not eligible if:
- they have undergone bone marrow transplant;
- they are paediatric patients (due to vaccinations not being undertaken in this population at the start of this study, this may be revisited at a later date)
Pays:
Investigateur principal:
Morag Griffin
Coordinateur EBMT de l'étude:
Inge Verheggen
E-mail du coordinateur de l'étude:
saawpebmt@lumc.nl